Zepbound and Mounjaro are both FDA-approved brand-name tirzepatide medications manufactured by Eli Lilly and Company, not compounded preparations
The initial correlation analysis revealed that gender, age, baseline body mass index, diabetes duration, and chronic comorbidities showed no significant association with muscle mass loss
Always consult with a healthcare provider to determine if these injections are right for you and to tailor the treatment to your specific needs
You must tell your surgical and anaesthetic team that you are taking tirzepatide, well in advance
Generally no you use one or the other on a given fill, not both at once
Contact UMR representatives directly for the most up-to-date, plan-specific information about weight loss medication coverage